Schick signs for $5 million credit, loses CFO

Article

In an effort to bolster its business, digital detector developer Schick Technologies of Long Island City, NY, has signed a commitment letter with investment firm Greystone & Co. to provide Schick with a $5-million line of credit, subject to final

In an effort to bolster its business, digital detector developer Schick Technologies of Long Island City, NY, has signed a commitment letter with investment firm Greystone & Co. to provide Schick with a $5-million line of credit, subject to final agreement. Under terms of the deal, Greystone will gain rights to purchase Schick common stock and will fill two seats on the firm’s board of directors. Schick expects the transaction to close by early November.

On the management side, Schick announced the resignation of its CFO, George Rough, and that it has begun the search for his replacement. The company also named John Pauly to the post of chief operating officer. Pauly is president and CEO of PFCM Corp., a professional services company that provides management consulting services worldwide.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.